Results 161 to 170 of about 1,909,793 (171)

Long-Term Safety of Drug-Eluting and Bare-Metal Stents: Evidence From a Comprehensive Network Meta-Analysis.

Journal of the American College of Cardiology, 2015
Giuseppe Biondi-Zoccai, Georgios J Vlachojannis   +1 more
exaly  

Restenosis Following Implantation of Bare Metal Coronary Stents: Pathophysiology and Pathways Involved in the Vascular Response to Injury

Advanced Drug Delivery Reviews, 2006
Neal A Scott
exaly  

Stent Thrombosis With Drug-Eluting and Bare-Metal Stents

Lancet, The, 2012
Christiaan J M Vrints
exaly  

Single-Dose Brachytherapy Versus Metal Stent Placement for the Palliation of Dysphagia From Oesophageal Cancer: Multicentre Randomised Trial

Lancet, The, 2004
Marjolein Y V Homs, Ernst Kuipers
exaly  

Risk of Stent Thrombosis Among Bare-Metal Stents, First-Generation Drug-Eluting Stents, and Second-Generation Drug-Eluting Stents: Results From a Registry of 18,334 Patients.

JACC: Cardiovascular Interventions, 2013
Robert A Byrne, Stefanie Schulz-Schüpke, Adnan Kastrati   +2 more
exaly  

Clinical Outcomes in Patients With ST-Segment Elevation Myocardial Infarction Treated With Everolimus-Eluting Stents Versus Bare-Metal Stents (EXAMINATION): 5-Year Results of a Randomised Trial

Lancet, The, 2016
Salvatore Brugaletta, Pilar Jiménez-Quevedo, Manel Sabaté   +2 more
exaly  

Biodegradable-Polymer Drug-Eluting Stents vs. Bare Metal Stents vs. Durable-Polymer Drug-Eluting Stents: A Systematic Review and Bayesian Approach Network Meta-Analysis

European Heart Journal, 2014
Woo-Hyun Lim, Jung-Kyu Han
exaly  

Are Drug-Eluting Stents Safer Than Bare-Metal Stents?

Lancet, The, 2019
Lisette Okkels Jensen
exaly  

Clinical Outcomes With Drug-Eluting and Bare-Metal Stents in Patients With ST-Segment Elevation Myocardial Infarction: Evidence From a Comprehensive Network Meta-Analysis.

Journal of the American College of Cardiology, 2013
Giacomo Frati, Giuseppe Biondi-Zoccai, Manel Sabaté   +2 more
exaly  

Drug-Eluting Versus Bare-Metal Stents in Saphenous Vein Graft Lesions (ISAR-CABG): A Randomised Controlled Superiority Trial

Lancet, The, 2011
Robert A Byrne, Stefanie Schulz-Schüpke, Julinda Mehilli   +2 more
exaly